Approval · Notice of Compliance 5748 · 1994
SUBLIMAZE: Notice of Compliance 5748
Issued June 23, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5748
- Date
- June 23, 1994
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of finished product
- Therapeutic class
- Narcotic analgesic, adjunct to anaesthesia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUBLIMAZE | Not yet assigned | — |
Medicinal ingredients
- FENTANYL CITRATE 50 MCG per ML